Results 41 to 50 of about 25,067 (232)

Inhalation therapy in mechanical ventilation

open access: yesJornal Brasileiro de Pneumologia, 2015
Patients with obstructive lung disease often require ventilatory support via invasive or noninvasive mechanical ventilation, depending on the severity of the exacerbation.
Juçara Gasparetto Maccari   +5 more
doaj   +1 more source

Clinical Outcomes and Acute Exacerbation Incidence in Combined Pulmonary Fibrosis and Emphysema

open access: yesRespirology, EarlyView.
This multicentre prospective study of 1016 patients demonstrated that CPFE, defined as ≥ 5% emphysema on visual CT assessment, identified a high‐risk phenotype with significantly worse 5‐year survival compared to non‐CPFE IIP patients (51.4% vs. 63.1%) and COPD patients (51.4% vs. 84.0%) and higher acute exacerbation incidence, validating international
Kazuya Tsubouchi   +23 more
wiley   +1 more source

Pulmonologists’ Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey

open access: yesInternational Journal of COPD, 2022
Marc Miravitlles,1,2 Fernando González-Torralba,3 Cristina Represas-Represas,4 Xavier Pomares,2,5 Eduardo Márquez-Martín,2,6 Cruz González,7 Carlos Amado,8 Carles Forné,9,10 Soledad Alonso,11 Bernardino Alcázar,12 Miriam Barrecheguren,1 Juan María Jurado
Miravitlles M   +12 more
doaj  

Three Spirometry‐Based At‐Risk Phenotypes Predict Incident Airflow Limitation: A Population‐Based Study

open access: yesRespirology, EarlyView.
Analysing the population‐based KORA and SHIP studies, three spirometric at‐risk subtypes (early airflow limitation, PRISm, and small airway dysfunction) were consistently associated with incident airflow limitation. Their combination in a conceptual framework identified most future cases with high negative predictive value, suggesting potential for ...
Hendrik Pott   +16 more
wiley   +1 more source

Long-term safety and efficacy of formoterol fumarate inhalation solution in patients with moderate-to-severe COPD

open access: yesInternational Journal of COPD, 2018
Nicola A Hanania,1 Sanjay Sethi,2 Arkady Koltun,3 Jonathan K Ward,4 Jacqui Spanton,4 Dik Ng4 1Asthma Clinical Research Center, Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA; 2Pulmonary, Critical Care, and ...
Hanania NA   +5 more
doaj  

Therapies for bronchiectasis: mechanisms and potential effects

open access: yesFrontiers in Immunology
Bronchiectasis is a complex and heterogeneous disease, and our current understanding of its pathophysiological mechanisms remains in its infancy. Currently, few specifically approved treatments for non-cystic fibrosis bronchiectasis are applied globally,
Long Yu   +4 more
doaj   +1 more source

Clinical characteristics of immediate allergic adverse reactions to intravenous amoxicillin‒clavulanic acid in conscious dogs

open access: yesVeterinary Record, EarlyView.
Abstract Background Amoxicillin‒clavulanic acid (AMC) is one of the most frequently used antibiotics in small animal practice, and reports on adverse reactions are scarce. The aim of this study was to describe the clinical characteristics of immediate allergic adverse reactions to intravenous (IV) AMC in conscious dogs. Methods The medical records of a
Leonel Frutuoso, Anna Threlfall
wiley   +1 more source

Small Airways Dysfunction and Remission in Adults With Asthma: A Longitudinal Exploratory Analysis of the AssessmenT of smalL Airways involvemeNT In aSthma (ATLANTIS) Study

open access: yesAllergy, EarlyView.
We conducted a post hoc analysis of ATLANTIS, a multinational prospective study including 684 adults with asthma. Fewer small airway symptoms and lower disease activity are independently associated with asthma remission. Replicated airway transcriptomic signatures show increased IL‐4/13 signalling and reduced coagulation pathways across the ATLANTIS ...
Akshi Kumar   +14 more
wiley   +1 more source

Do 'guidelines' really guide us? [PDF]

open access: yesABC: časopis urgentne medicine, 2017
INTRODUCTION Chronic obstructive pulmonary disease (COPD) is a disease that can be prevented and treated. It is characterized by permanent limitation of the airflow through respiratory tract, which is usually progressive and associated with an increased ...
Milićević-Nešić Ivana J.
doaj  

Pharmacological Treatment in Asthma and COPD

open access: yesAllergology International, 2009
Many lines of previous studies have reported that differences and similarities between bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD). The pathological and physiological abnormalities of these diseases have been also discussed. BA
Tomoaki Hoshino   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy